Effects of anamorelin on microbiota
Not Applicable
- Conditions
- Cancer cachexia
- Registration Number
- JPRN-UMIN000047574
- Lead Sponsor
- Cancer Treament Center, Kansai Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with a prognosis of 12 weeks or less Previous anamorelin administration Patients with concomitant severe cardiac disease Hepatic dysfunction (Child-Pugh B or C) Difficulty with oral intake due to organic abnormalities (e.g. obstruction) of the gastrointestinal tract Other patients who are deemed inappropriate by the principal investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the diversity of intestinal microbiota before and after anamorelin administration
- Secondary Outcome Measures
Name Time Method Change in body weight Percent change in EORTC-QLQ-C15PAL score Percent change in appetite-related items in EORTC-QLQ-C15PAL score